SK282970B6 - Deriváty 1H-pyrido[3,4-b]indol-4-karboxamidu, farmaceutická kompozícia, ktorá ich obsahuje, a spôsob ich prípravy - Google Patents

Deriváty 1H-pyrido[3,4-b]indol-4-karboxamidu, farmaceutická kompozícia, ktorá ich obsahuje, a spôsob ich prípravy Download PDF

Info

Publication number
SK282970B6
SK282970B6 SK451-99A SK45199A SK282970B6 SK 282970 B6 SK282970 B6 SK 282970B6 SK 45199 A SK45199 A SK 45199A SK 282970 B6 SK282970 B6 SK 282970B6
Authority
SK
Slovakia
Prior art keywords
formula
group
compound
indole
mmol
Prior art date
Application number
SK451-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK45199A3 (en
Inventor
Yannick Evanno
Mireille Sevrin
Christian Maloizel
Odette Legalloudec
Pascal George
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK45199A3 publication Critical patent/SK45199A3/sk
Publication of SK282970B6 publication Critical patent/SK282970B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
SK451-99A 1996-10-08 1997-10-03 Deriváty 1H-pyrido[3,4-b]indol-4-karboxamidu, farmaceutická kompozícia, ktorá ich obsahuje, a spôsob ich prípravy SK282970B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612229A FR2754262B1 (fr) 1996-10-08 1996-10-08 Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
PCT/FR1997/001750 WO1998015552A1 (fr) 1996-10-08 1997-10-03 DERIVES DE 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
SK45199A3 SK45199A3 (en) 2000-02-14
SK282970B6 true SK282970B6 (sk) 2003-01-09

Family

ID=9496449

Family Applications (1)

Application Number Title Priority Date Filing Date
SK451-99A SK282970B6 (sk) 1996-10-08 1997-10-03 Deriváty 1H-pyrido[3,4-b]indol-4-karboxamidu, farmaceutická kompozícia, ktorá ich obsahuje, a spôsob ich prípravy

Country Status (33)

Country Link
US (1) US6075021A (pt)
EP (1) EP0934319B1 (pt)
JP (1) JP4227197B2 (pt)
KR (1) KR100488095B1 (pt)
CN (1) CN1089765C (pt)
AR (1) AR009112A1 (pt)
AT (1) ATE218567T1 (pt)
AU (1) AU721102B2 (pt)
BG (1) BG63751B1 (pt)
BR (1) BR9711879A (pt)
CA (1) CA2266376A1 (pt)
CO (1) CO4910141A1 (pt)
CY (1) CY2291B1 (pt)
CZ (1) CZ298906B6 (pt)
DE (1) DE69713124T2 (pt)
DK (1) DK0934319T3 (pt)
EE (1) EE03830B1 (pt)
ES (1) ES2178008T3 (pt)
FR (1) FR2754262B1 (pt)
HK (1) HK1023338A1 (pt)
HU (1) HUP9904623A3 (pt)
IL (1) IL129018A0 (pt)
NO (1) NO311938B1 (pt)
NZ (1) NZ334708A (pt)
PL (1) PL188244B1 (pt)
PT (1) PT934319E (pt)
RU (1) RU2180904C2 (pt)
SK (1) SK282970B6 (pt)
TR (1) TR199900712T2 (pt)
TW (1) TW461889B (pt)
UA (1) UA57037C2 (pt)
WO (1) WO1998015552A1 (pt)
ZA (1) ZA978970B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788696B1 (fr) 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
EP1590349A1 (en) * 2003-01-27 2005-11-02 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
EP1751157B1 (en) * 2004-04-26 2007-10-03 Pfizer Inc. Inhibitors of the hiv integrase enzyme
BRPI0510319A (pt) * 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
JP5483874B2 (ja) * 2005-05-05 2014-05-07 サノフィ−アベンティス・ユー・エス・エルエルシー 安定なナノ粒子処方物
CA2623506A1 (en) * 2005-10-07 2007-04-19 Pfizer Products Inc. Inhibitors of the hiv integrase enzyme
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
ATE486862T1 (de) * 2006-06-05 2010-11-15 Novartis Ag Organische verbindungen
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
KR100688448B1 (ko) * 2006-12-06 2007-03-02 (주)경진건축사사무소 건축물 내부 조적구조

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament

Also Published As

Publication number Publication date
DE69713124D1 (de) 2002-07-11
ATE218567T1 (de) 2002-06-15
CN1089765C (zh) 2002-08-28
FR2754262A1 (fr) 1998-04-10
ES2178008T3 (es) 2002-12-16
KR20000048992A (ko) 2000-07-25
EP0934319B1 (fr) 2002-06-05
DK0934319T3 (da) 2002-09-30
CO4910141A1 (es) 2000-04-24
NO991624L (no) 1999-06-07
UA57037C2 (uk) 2003-06-16
NO991624D0 (no) 1999-04-06
KR100488095B1 (ko) 2005-05-09
PL188244B1 (pl) 2005-01-31
BG63751B1 (bg) 2002-11-29
US6075021A (en) 2000-06-13
TR199900712T2 (xx) 1999-06-21
HUP9904623A2 (hu) 2000-06-28
DE69713124T2 (de) 2003-01-30
EE9900155A (et) 1999-12-15
BG103301A (en) 2000-05-31
IL129018A0 (en) 2000-02-17
HK1023338A1 (en) 2000-09-08
JP2001508403A (ja) 2001-06-26
WO1998015552A1 (fr) 1998-04-16
HUP9904623A3 (en) 2001-03-28
SK45199A3 (en) 2000-02-14
NZ334708A (en) 2000-10-27
PT934319E (pt) 2002-10-31
AR009112A1 (es) 2000-03-08
AU721102B2 (en) 2000-06-22
CZ298906B6 (cs) 2008-03-12
EP0934319A1 (fr) 1999-08-11
FR2754262B1 (fr) 1998-10-30
TW461889B (en) 2001-11-01
CY2291B1 (en) 2003-07-04
RU2180904C2 (ru) 2002-03-27
ZA978970B (en) 1998-04-20
NO311938B1 (no) 2002-02-18
BR9711879A (pt) 1999-08-24
PL332643A1 (en) 1999-09-27
CA2266376A1 (en) 1998-04-16
EE03830B1 (et) 2002-08-15
CN1233248A (zh) 1999-10-27
AU4559497A (en) 1998-05-05
JP4227197B2 (ja) 2009-02-18
CZ119399A3 (cs) 1999-07-14

Similar Documents

Publication Publication Date Title
AU2016340527B2 (en) Heterocyclic compound
SK282970B6 (sk) Deriváty 1H-pyrido[3,4-b]indol-4-karboxamidu, farmaceutická kompozícia, ktorá ich obsahuje, a spôsob ich prípravy
AU2011288876A2 (en) Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
CA2471348A1 (en) Quinazolinone derivative
JP2007502307A (ja) グルタミン酸ラセマーゼ（ｍｕｒｉ）の阻害剤としての縮合複素環
GB2158825A (en) Naphthyridines
PT2252611E (pt) (di-hidro)pirrolo[2,1-a]isoquinolinas
JPH0568474B2 (pt)
ES2269822T3 (es) Derivados de pirazol de anillos fusionados.
KR100497782B1 (ko) 4-옥소-3,5-디히드로-4Ｈ-피리다지노[4,5-ｂ]인돌-1-아세트아미드 유도체, 그것의 제조 및 치료에서의 그것의 응용
EP0619820A1 (en) Imidazoquinazoline compounds and their preparation and use
EP2166852A1 (en) Therapeutic pyrazoloquinoline derivatives
EP1176146B1 (en) Carbamoyl tetrahydropyridine derivatives
US5466706A (en) 9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
CN116669738A (zh) 一种作为sos1抑制剂的嘧啶并吡啶酮类衍生物、其制备方法及用途
US5512590A (en) 5,6-dihydro-4h-imidazo 2',1':2,3!imidazo- 4,5,1-ij!quinoline and 4,5-dihydroimidazo- 1,2-a!pyrolo 1,2,3-cd!benzimidazole derivatives, their preparation and application in therapeutics
JP5570981B2 (ja) キナーゼ阻害剤としての縮合チアゾール誘導体
DE69526106T2 (de) Pyridazinochinolinverbindungen
MXPA99003254A (es) Derivados de 1h-pirido(3-4-b)indol-4-carboxamida, preparacion y aplicacion de los mismos en terapeutica
WO2024067694A1 (zh) 含氮杂环类化合物及其医药用途
CN114401715A (zh) 抑制usp19

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20121003